Thank you for your interest in the RESET-RA study.
Based on your responses and your medication history, you do not meet the eligibility for this study at this moment. Participation in this study requires that you are on a stable dose of a conventional RA drugs, called DMARDs, such as methotrexate, hydroxychloroquine, leflunomide, or sulfasalazine.
You can discuss your treatment options with your current rheumatologist and share your interest in participation in the RESET-RA study. Please click here to view and print study information that you can share with your doctor.
With your permission, we can also email you this information.